Drug-Eluting Stents – a Panacea for Everyone or Not? Commentary on the Paper «Perioperative Myocardial Infarction and Successful Revascularization in Patient With Primary Metasynchronic Rectal, Gastric and Bladder Cancer»
https://doi.org/10.18087/cardio.2024.10.n2772
Abstract
The article discusses long-term safety of drug-eluting stents in emergent coronary revascularization.
About the Author
I. V. PershukovRussian Federation
MD, DSc, Professor, FACC, FSCAI,
cardiologist, interventional radiologist, CV surgeon
Osh, Kyrgyzstan; Almaty, Kazakhstan; Bobrov, Russia
References
1. Pituskin E, Joy AA, Fairchild A. Advanced Cancer as a Chronic Disease: Introduction. Seminars in Oncology Nursing. 2021;37(4):151176. DOI: 10.1016/j.soncn.2021.151176
2. Lage A, Crombet T. Control of Advanced Cancer: The Road to Chronicity. International Journal of Environmental Research and Public Health. 2011;8(3):683–97. DOI: 10.3390/ijerph8030683
3. Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM et al. Cancer treatment and survivorship statistics, 2019. CA: A Cancer Journal for Clinicians. 2019;69(5):363–85. DOI: 10.3322/caac.21565
4. Arantzamendi M, García-Rueda N, Carvajal A, Robinson CA. People With Advanced Cancer: The Process of Living Well With Awareness of Dying. Qualitative Health Research. 2020;30(8):1143–55. DOI: 10.1177/1049732318816298
5. Florido R, Daya NR, Ndumele CE, Koton S, Russell SD, Prizment A et al. Cardiovascular Disease Risk Among Cancer Survivors. Journal of the American College of Cardiology. 2022;80(1):22–32. DOI: 10.1016/j.jacc.2022.04.042
6. Potievskaya V.I., Choronenko V.E., Loenko V.B., Rerberg A.G., Bagiyan E.R. Perioperative Myocardial Infarction and Successful Revascularization in Patient With Primary Metasynchronic Rectal, Gastric and Bladder Cancer. Kardiologiia. 2024;64(10):68–73. DOI: 10.18087/cardio.2024.10.n2659
7. Belenkov Yu.N., Batyraliev T.A., Pershukov I.V. Invasive cardiology – focus on restenosis. Part I. Kardiologiia. 2002;42(8):50–6.
8. Belenkov Yu.N., Batyraliev T.A., Pershukov I.V., Samko A.N. Invasive cardiology--focus on restenosis. Part II. Kardiologiia. 2002;42(11):68–72.
9. Piccolo R, Esposito G. Device Comparisons in the New-Generation Drug-Eluting Stent Era: Continued Refinements in Stent Technology. JACC: Cardiovascular Interventions. 2020;13(9):1110–1. DOI: 10.1016/j.jcin.2020.02.041
10. Cortese B, Testa G, Rivero F, Erriquez A, Alfonso F. Long-Term Outcome of Drug-Coated Balloon vs Drug-Eluting Stent for Small Coronary Vessels. JACC: Cardiovascular Interventions. 2023;16(9):1054–61. DOI: 10.1016/j.jcin.2023.02.011
11. Ferro A. Antithrombotic therapy after 1 year of dual antiplatelet therapy following acute coronary syndrome: What to do? International Journal of Cardiology. 2022;349:27–8. DOI: 10.1016/j.ijcard.2021.11.043
12. Oshiro N, Yoshino K, Hidayat S, Tokunaga C, Hara K, Eguchi S et al. Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function. Genes to Cells. 2004;9(4):359–66. DOI: 10.1111/j.1356-9597.2004.00727.x
13. Falanga A, Leader A, Ambaglio C, Bagoly Z, Castaman G, Elalamy I et al. EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer. HemaSphere. 2022;6(8):e750. DOI: 10.1097/HS9.0000000000000750
14. Belenkov Yu.N., Ilgisonis I.S., Khabarova N.V., Kirichenko Yu.Yu. Modern Instrumental Methods of Diagnostics and Risk Assessment of Developing Antitumor Therapy Cardiovasculotoxicity. Kardiologiia. 2024;64(8):3–12. DOI: 10.18087/cardio.2024.8.n2753
Review
For citations:
Pershukov I.V. Drug-Eluting Stents – a Panacea for Everyone or Not? Commentary on the Paper «Perioperative Myocardial Infarction and Successful Revascularization in Patient With Primary Metasynchronic Rectal, Gastric and Bladder Cancer». Kardiologiia. 2024;64(10):74-76. (In Russ.) https://doi.org/10.18087/cardio.2024.10.n2772